| Literature DB >> 31089314 |
Fernando A Bessone1, Maria Laura Soriano Pérez1,2, Gustavo Zielinski1, Marina Dibarbora1,2, M B Conde1, Javier Cappuccio1,2, Fabrisio Alustiza1.
Abstract
BACKGROUND: Pasteurella multocida (Pm) is the causative agent of progressive atrophic rhinitis (PAR) and pneumonic pasteurellosis (PN) in pigs. Pm is a member of the porcine respiratory complex responsible for important economic loss in the pig industry. AIM: This study aimed to characterize the Pm strains recovered from clinical cases of PN and PAR and to elucidate the antibiotic susceptibility profiles of the strains.Entities:
Keywords: Pasteurella multocida; antibiotics susceptibility profiles; molecular characterization; pig
Year: 2019 PMID: 31089314 PMCID: PMC6487256 DOI: 10.14202/vetworld.2019.434-439
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Primers sequences of Pm virulence factor.
| Virulence factor | Description | Primer ID | Sequence 5×-3× | Amplicon size (bp) | References |
|---|---|---|---|---|---|
| Toxin A | CGTGAACTGCGTACTCAA | 1854 | [ | ||
| AAGAGGAGGCATGAAGAG | |||||
| Species-specific gene | ATCCGCTATTTACCCAGTGG | 460 | [ | ||
| GCTGTAAACGAACTCGCCAC | |||||
| Capsular type A | TGCCAAAATCGCAGTCAG | 1044 | [ | ||
| TTGCCATCATTGTCAGTG | |||||
| Capsular type D | TTACAAAAGAAAGACTAGGAGCCC | 657 | [ | ||
| CATCTACCCACTCAACCATATCAG |
Figure-1Electrophoresis gel of polymerase chain reaction products. Lane 1: CapD; Lane 2: KMT1; Lane 3: CapA; Lane 4: Negative control; Lane 5: CapD; Lane 6: Ladder (100bp).
Association of capsular types, presence of toxin, and pathogenicity of Pm isolates.
| Strain ID | Type A | Type D | Cap. ND | Tox A | PN | PAR |
|---|---|---|---|---|---|---|
| Pm001 | + | − | − | − | + | − |
| Pm002 | − | + | − | − | − | + |
| Pm003 | − | − | + | − | − | + |
| Pm005 | + | − | − | + | + | − |
| Pm006 | − | + | − | − | − | + |
| Pm008 | + | − | − | − | + | − |
| Pm010 | + | − | − | − | + | − |
| Pm011 | − | + | − | − | − | + |
| Pm012 | - | + | - | - | - | + |
| Pm014 | − | − | + | − | + | − |
| Pm017 | + | − | − | − | + | − |
| Pm019 | − | − | + | + | + | − |
| Pm020 | − | + | − | + | − | + |
| Pm021 | + | − | − | − | + | − |
| Pm025 | + | − | − | − | + | − |
| Pm026 | − | − | + | − | − | + |
| Pm028 | + | − | − | + | + | − |
| Pm029 | + | − | − | − | + | − |
| Pm031 | − | + | − | − | − | + |
| Pm032 | + | − | − | − | + | − |
| Pm038 | − | − | + | − | − | + |
| Pm040 | − | + | − | − | − | + |
| Pm041 | − | + | − | + | − | + |
| Pm042 | − | + | − | − | − | + |
| Pm043 | − | + | − | − | − | + |
| Pm044 | − | + | − | − | − | + |
| Pm048 | − | + | − | − | − | + |
| Pm049 | − | + | − | − | − | + |
| Pm052 | + | − | − | + | + | − |
| Pm053 | − | − | + | − | + | − |
| Pm054 | − | + | − | − | − | + |
| Pm061 | + | − | − | − | + | − |
| Pm063 | + | − | − | − | + | − |
| Pm066 | - | + | - | - | - | + |
| Pm073 | − | − | + | − | + | − |
| Pm074 | − | − | + | − | + | − |
| Pm075 | + | − | − | − | + | − |
| Pm076 | − | − | + | − | + | − |
| Pm079 | − | + | − | − | − | + |
| Pm080 | − | + | − | − | − | + |
| Pm084 | − | − | + | − | + | − |
| Pm086 | − | − | + | − | − | + |
| Pm093 | − | − | + | + | + | − |
| Pm095 | − | − | + | − | + | − |
| Pm097 | − | − | + | + | + | − |
| Pm098 | − | + | − | − | − | + |
| Pm099 | − | − | + | − | − | + |
| Pm100 | − | − | + | − | + | − |
| Pm101 | + | − | − | − | + | − |
| Pm103 | + | − | − | − | + | − |
| Pm104 | + | − | − | − | + | − |
| Pm106 | − | − | + | − | + | − |
| Pm107 | + | − | − | − | + | − |
| Pm108 | − | − | + | − | + | − |
| Pm109 | − | − | + | − | + | − |
| Pm110 | + | − | − | − | + | − |
| Pm111 | − | − | + | + | + | − |
| Pm112 | − | + | − | − | − | + |
| Pm113 | − | − | + | + | + | − |
| Pm114 | − | − | + | − | + | − |
| Total (%) | 19 (32.5) | 19 (32.5) | 22 (35) | 10 (16.6) | 36 (60) | 24 (40) |
References - Pm=Pasteurella multocida, PN=Pneumonic pasteurellosis, PAR=Progressive atrophic rhinitis, Cap ND=Capsular type not determined
Figure-2Profiles of antibiotic susceptibility of Pasteurella multocida strains.
Prevalent multiresistance profile.
| Multi-resistance profile | Frequency | Pathological condition | |
|---|---|---|---|
| PAR (n) | PN ((n) | ||
| Tilmicosin–Tylosin–Erythromycin | 10 (17) | 7 | 3 |
| Tilmicosin–Tylosin–Lincomycin | 10 (17) | 6 | 4 |
| Tilmicosin–Erythromycin–Lincomycin | 10 (17) | 6 | 4 |
| Tylosin–Erythromycin–Lincomycin | 33 (56) | 14 | 19 |
| Tylosin–Lincomycin–TMS | 5 (8.5) | 2 | 3 |
References -
These values are not additives. PAR=Progressive atrophic rhinitis, PN=Pneumonic pasteurellosis, TMS=Trimethoprim sulfamethoxazole
Figure-3Dendrogram shows conglomerates analysis of antibiotic profiles of Pasteurella multocida from progressive atrophic rhinitis and pneumonic pasteurellosis cases.